Back to Journals » OncoTargets and Therapy » Volume 9

Proton beam therapy: clinical utility and current status in prostate cancer

Authors Yamoah K, Johnstone P

Received 23 May 2016

Accepted for publication 10 August 2016

Published 16 September 2016 Volume 2016:9 Pages 5721—5727

DOI https://doi.org/10.2147/OTT.S100518

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 2

Editor who approved publication: Dr William Cho


Kosj Yamoah, Peter AS Johnstone

Radiation Oncology Department, Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Abstract: Proton beam therapy has recently become available to a broader population base. There remains much controversy about its routine use in prostate cancer. We provide an analysis of the existing literature regarding efficacy and toxicity of the technique. Currently, the use of proton beam therapy for prostate cancer is largely dependent on continued reimbursement for the practice. While there are potential benefits supporting the use of protons in prostate cancer, the low risk of toxicity using existing techniques and the high cost of protons contribute to lower the value of the technique.

Keywords: proton therapy, prostate cancer, radiotherapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]